Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test |
Kim, Seung Youn
(Department of Pediatrics, Korean Cancer Center Hospital)
Kim, Yun Kyung (Department of Pediatrics, Korea University College of Medicine) Eun, Byung Wook (Department of Pediatrics, Graduate School of Medicine, Gachon University of Medicine and Science) Kim, Nam Hee (Department of Pediatrics, Inje University Ilsan Paik Hospital, Inje University College of Medicine) Kang, Eun Kyeong (Department of Pediatrics, Dongguk University Ilsan Hospital) Lee, Byong Sop (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine) Lim, Jung Sub (Department of Pediatrics, Korean Cancer Center Hospital) Lee, Jun Ah (Department of Pediatrics, Korean Cancer Center Hospital) Kim, Dong Ho (Department of Pediatrics, Korean Cancer Center Hospital) |
1 | Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342:225-31. DOI ScienceOn |
2 | Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342:232-9. DOI ScienceOn |
3 | Neuzil KM, Zhu Y, Griffin MR, Edwards KM, Thompson JM, Tollefson SJ, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002;185:147-52. DOI ScienceOn |
4 | Heikkinen T, Silvennoinen H, Peltola V, Ziegler T, Vainionpaa R, Vuorinen T, et al. Burden of influenza in children in the community. J Infect Dis 2004;190:1369-73. DOI ScienceOn |
5 | European Medicines Agency. Committee for proprietary medicinal products (CPMP). CPMP/BWP/214/96. Note for guidance on harmonization of requirements for influenza vaccines. London: European Medicines Agency; c1995-2012 [cited 2004 Dec 2]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_ guideline/2009/09/WC500003945.pdf. |
6 | Potter CW, Oxford JS. Determinants of immunity to influenza infection in man. Br Med Bull 1979;35:69-75. DOI |
7 | Kayhty H. Immunogenicity assays and surrogate markers to predict vaccine efficacy. Dev Biol Stand 1998;95:175-80. |
8 | Arizona Department of Health Services, Division of Public Health Services, Bureau of State Laboratory Services. Modern methods for influenza detection and subtyping [Internet]. Phoenix: Arizona Department of Health Services; c2009-2012 [cited 2012 Nov 22]. Available from: http://www.azdhs.gov/lab. |
9 | Okuno Y, Tanaka K, Baba K, Maeda A, Kunita N, Ueda S. Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system. J Clin Microbiol 1990;28:1308-13. |
10 | Monto AS. Vaccines and antiviral drugs in pandemic preparedness. Emerg Infect Dis 2006;12:55-60. DOI |
11 | Davenport FM, Hennessy AV, Francis T Jr. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med 1953;98:641-56. DOI ScienceOn |
12 | World Health Organization, Department of Communicable Disease Surveillance and Response. WHO manual on animal influenza diagnosis and surveillance. 2002.5. Rev. 1 [Internet]. Geneva: World Health Organization; c2012 [cited 2012 Apr 12]. Available from: http://http://www.who.int/csr/resources/publications/influenza/en/ whocdscsrncs20025rev.pdf. |
13 | Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972;70:767-77. DOI |
14 | Benne CA, Harmsen M, De Jong JC, Kraaijeveld CA. Neutralization enzyme immunoassay for influenza virus. J Clin Microbiol 1994;32:987-90. |
15 | Gruber WC, Taber LH, Glezen WP, Clover RD, Abell TD, Demmler RW, et al. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child 1990;144:595-600. |
16 | Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999;37:937-43. |
17 | Tobita K, Sugiura A, Enomote C, Furuyama M. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med Microbiol Immunol 1975;162:9-14. DOI ScienceOn |
18 | Centers for Disease Control and Prevention (CDC). Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009;58:521-4. |
19 | Beyer WE, Palache AM, Osterhaus AD. Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines: a review and meta-analysis of the literature. Clin Drug Investig 1998;15:1-12. |
20 | Murphy BR, Nelson DL, Wright PF, Tierney EL, Phelan MA, Chanock RM. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun 1982;36:1102-8. |
21 | Murphy BR, Kasel JA, Chanock RM. Association of serum antineuraminidase antibody with resistance to influenza in man. N Engl J Med 1972;286:1329-32. DOI ScienceOn |
22 | Couch RB, Kasel JA. Immunity to influenza in man. Annu Rev Microbiol 1983;37:529-49. DOI ScienceOn |